4//SEC Filing
Goldberg Andrew D. 4
Accession 0001819790-23-000043
CIK 0001819790other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:18 PM ET
Size
282.0 KB
Accession
0001819790-23-000043
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-06-16−2,000→ 0 total→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2023-06-16+2,000→ 2,000 total
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827722
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:18 PM ET
- Size
- 282.0 KB